Workday (NASDAQ:WDAY – Get Free Report)‘s stock had its “market outperform” rating reiterated by research analysts at JMP ...
Enova International (NYSE:ENVA – Free Report) had its target price upped by JMP Securities from $125.00 to $135.00 in a ...
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
周五,JMP Securities重申了对Sprinklr Inc (NYSE: CXM )的"市场跑赢"评级,维持目标价17.00美元不变。该公司分析师强调了公司当前的业绩表现,包括第三财季8%的增长和12%的营业利润率。公司展现出稳健的基本面,过去十二个月毛利率达73.29%,营收为7.8806亿美元。根据 InvestingPro ...
周四,JMP Securities重申了对Cytokinetics(NASDAQ:CYTK)的"优于大市"评级和78.00美元的目标价。尽管该股周三大跌8.4%(相比之下XBI生物科技指数下跌1.4%),该机构仍维持这一评级。目前该股交易价格为46.17美元,接近其52周低点44.49美元。 InvestingPro ...
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...
Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results